Introduction HIV infection and combined antiretroviral therapy (cART) are associated with chronic immune activation, which can contribute to the development of metabolic problems and chronic diseases, e.g., cardiovascular diseases, type-2 diabetes. In the general population moderate physical activity has shown to reduce both inflammation and burden of chronic diseases. Aim of this study was to evaluate the effects of brisk walking, as moderate aerobic exercise, on physical fitness, metabolic measures and soluble and cell inflammatory markers among HIV-infected treated subjects. Methods A pilot study was designed including HIV-infected, cART-treated, sedentary subjects with metabolic problems, in a 12-week protocol consisting of 3 outdoor sessions/week of 60 min brisk walking at 65-75% of HRmax with (“walk-strength” group) or without (“walk” group) 30 min circuit training at 65% of 1-ripetition maximum (RM). Measures at baseline (BL) and at week 12 (W12) included distance walked at 6 minute walking test (6MWT) and 1-RM Test; morphometric measures; fasting lipid and glucose blood profile; plasma level of d-dimer, high-sensitivity CRP (hsCRP), interleukin-6 (IL-6), interleukin-18 (IL-18), soluble CD14 (sCD14), myostatin, and CD38 and HLA-DR expression on CD4+ and CD8+ cells. Differences between groups were tested by the Mann-Whitney test and W12 changes from BL by the Wilcoxon-signed rank test. Results are expressed as median values. Results Forty-nine subjects were enrolled and 35 completed the 12-week program: 14 in the ’walk-strength’ group and 21 in the ’walk” group. Median adherence was 67%. At W12, significant improvements from BL were observed of both aerobic and strength performance, with a 14% improvement of distance walked during 6MWT, of BMI, waist and hip circumference, and total and LDL cholesterol, without differences between training groups. Significant reductions were observed of plasma levels of d-dimer (from 272 to 181 ng/mL, p=0.0002), hCRP (from 2.02 to 1.14 μg/mL, p=0.001), IL-6 (from 4.63 to 4.47 pg/mL, p=0.021), IL-18 (from 354 to 304 pg/mL, p=0.010) and myostatin (from 20.9 to 13.5 pg/mL, p=0.006), and of frequency of CD8+CD38+ (from 10.19 to 10.23%, p=0.010), CD8+HLA-DR+ (from 4.34 to 1.79%, p=0.001) and CD4+HLA-DR+ cells (from 10.87 to 6.85%, p=0.024). Conclusions A 12-week protocol of brisk walking was associated with a significant reduction of immune activation in HIV- treated subjects with metabolic disorders. Moderate physical activity can be proposed as a strategy to control long-term consequences of treated HIV infection.

A pilot study of moderate physical activity in HIV-infected persons receiving anti-HIV drugs : benefits on soluble and cell markers of inflammation / M. Bonato, V. Longo, S. Bossolasco, G. Pavei, L. Galli, G. Merati, A. La Torre, P. Cinque - In: Book of abstracts of the 19th Annual Congress of the European College of Sport Science, 2nd - 5th July 2014, Amsterdam – The Netherlands BOOK OF ABSTRACTS / [a cura di] A. De Haan, C.J. De Ruiter, E. Tsolakidis. - Utrecht : European College of Sport Science, 2014 Jul. - ISBN 978-94-622-8477-7. - pp. 142-142 (( Intervento presentato al 19. convegno Annual Congress of the European College of Sport Science tenutosi a Amsterdam nel 2014.

A pilot study of moderate physical activity in HIV-infected persons receiving anti-HIV drugs : benefits on soluble and cell markers of inflammation

M. Bonato;G. Pavei;G. Merati;A. La Torre;
2014-07

Abstract

Introduction HIV infection and combined antiretroviral therapy (cART) are associated with chronic immune activation, which can contribute to the development of metabolic problems and chronic diseases, e.g., cardiovascular diseases, type-2 diabetes. In the general population moderate physical activity has shown to reduce both inflammation and burden of chronic diseases. Aim of this study was to evaluate the effects of brisk walking, as moderate aerobic exercise, on physical fitness, metabolic measures and soluble and cell inflammatory markers among HIV-infected treated subjects. Methods A pilot study was designed including HIV-infected, cART-treated, sedentary subjects with metabolic problems, in a 12-week protocol consisting of 3 outdoor sessions/week of 60 min brisk walking at 65-75% of HRmax with (“walk-strength” group) or without (“walk” group) 30 min circuit training at 65% of 1-ripetition maximum (RM). Measures at baseline (BL) and at week 12 (W12) included distance walked at 6 minute walking test (6MWT) and 1-RM Test; morphometric measures; fasting lipid and glucose blood profile; plasma level of d-dimer, high-sensitivity CRP (hsCRP), interleukin-6 (IL-6), interleukin-18 (IL-18), soluble CD14 (sCD14), myostatin, and CD38 and HLA-DR expression on CD4+ and CD8+ cells. Differences between groups were tested by the Mann-Whitney test and W12 changes from BL by the Wilcoxon-signed rank test. Results are expressed as median values. Results Forty-nine subjects were enrolled and 35 completed the 12-week program: 14 in the ’walk-strength’ group and 21 in the ’walk” group. Median adherence was 67%. At W12, significant improvements from BL were observed of both aerobic and strength performance, with a 14% improvement of distance walked during 6MWT, of BMI, waist and hip circumference, and total and LDL cholesterol, without differences between training groups. Significant reductions were observed of plasma levels of d-dimer (from 272 to 181 ng/mL, p=0.0002), hCRP (from 2.02 to 1.14 μg/mL, p=0.001), IL-6 (from 4.63 to 4.47 pg/mL, p=0.021), IL-18 (from 354 to 304 pg/mL, p=0.010) and myostatin (from 20.9 to 13.5 pg/mL, p=0.006), and of frequency of CD8+CD38+ (from 10.19 to 10.23%, p=0.010), CD8+HLA-DR+ (from 4.34 to 1.79%, p=0.001) and CD4+HLA-DR+ cells (from 10.87 to 6.85%, p=0.024). Conclusions A 12-week protocol of brisk walking was associated with a significant reduction of immune activation in HIV- treated subjects with metabolic disorders. Moderate physical activity can be proposed as a strategy to control long-term consequences of treated HIV infection.
HIV ; moderate physical activity ; inflammation
Settore M-EDF/02 - Metodi e Didattiche delle Attivita' Sportive
European College of Sport Science
VU University Amsterdam
VU University Medical Center Amsterdam
Book Part (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/237784
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact